Author: Drue De Angelis

Histogenics Corporation to Present at Upcoming Investor Conferences
Biologics

Histogenics Corporation to Present at Upcoming Investor Conferences

WALTHAM, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) — Histogenics Corporation (Histogenics) (HSGX), a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced that Company Management will be presenting at two upcoming healthcare investor conferences. Cowen and Company 37th Annual Health Care Conference – Boston, […]

Wright Medical reports 2016 Fourth Quarter and Full-Year Financial results
Financial

Wright Medical reports 2016 Fourth Quarter and Full-Year Financial results

AMSTERDAM, The Netherlands, Feb. 21, 2017 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (NASDAQ:WMGI) today reported financial results for its fourth quarter and full-year ended December 25, 2016 and provided 2017 guidance. As a result of the previously announced sale of the large joints (hip/knee) business to Corin Orthopaedics Holdings Limited […]

Bioness Announces First European Implants for StimRouter Neuromodulation System
Extremities Neuro

Bioness Announces First European Implants for StimRouter Neuromodulation System

VALENCIA, Calif., Feb. 22, 2017 /PRNewswire/ — Bioness, Inc., the leading provider of cutting edge, clinically supported rehabilitation therapies, today announced the first series of successful StimRouter Neuromodulation System implantations in Europe at Radboud University Medical Center (Nijmegen, Netherlands), South Victoria University (Cork, Ireland), and Kliniek Park Leopold Chirec (Brussels, Belgium). […]

SANUWAVE Announces Hiring of Andre Mouton as VP of International Sales and Relations
Biologics

SANUWAVE Announces Hiring of Andre Mouton as VP of International Sales and Relations

SUWANEE, GA–(Marketwired – Feb 21, 2017) – SANUWAVE Health, Inc. ( OTCQB : SNWV ) is pleased to announce the hiring of André Mouton to head the Company’s international sales and relations. SANUWAVE began a process 18 months ago of re-igniting their international efforts. This meant re-designing distribution agreements, restructuring partner economics, […]

Wenzel Spine Announces Acquisition of Interspinous & Facet Fixation Product Platforms
Spine

Wenzel Spine Announces Acquisition of Interspinous & Facet Fixation Product Platforms

February 22, 2017 AUSTIN, Texas–(BUSINESS WIRE)– Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced that it has completed the acquisition of the PrimaLOK™ SP Interspinous Fusion System and PrimaLOK™ FF Facet Fixation System from OsteoMed, LLC. The […]

TransEnterix Schedules Fourth Quarter and Fiscal Year 2016 Financial and Operating Results Conference Call for March 6, 2017
Financial

TransEnterix Schedules Fourth Quarter and Fiscal Year 2016 Financial and Operating Results Conference Call for March 6, 2017

February 21, 2017 RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release fourth quarter and fiscal year 2016 financial and operating results after the market closes on Monday, March 6, 2017. Todd M. Pope, President and Chief Executive Officer and Joseph P. Slattery, […]

VEXIM: another major step towards the SpineJack® commercialization in the US
Spine

VEXIM: another major step towards the SpineJack® commercialization in the US

Toulouse, February 21st, 2017 (8:00AM CET) – VEXIM (FR0011072602 – ALVXM), a medical device company specializing in the minimally-invasive treatment of vertebral fractures, today announces enrollment completion of its FDA clinical trial. The VEXIM FDA trial is a European, prospective and randomized multicenter study. It aims to compare safety and […]

Orthofix International Schedules Fourth Quarter 2016 and Fiscal Year 2016 Earnings Release and Conference Call for February 27, 2017
Financial

Orthofix International Schedules Fourth Quarter 2016 and Fiscal Year 2016 Earnings Release and Conference Call for February 27, 2017

February 16, 2017 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ:OFIX) (the “Company”) a diversified, global medical device company, today announced that it plans to release financial results for the fourth quarter and fiscal year 2016 after market close on Monday, February 27, 2017. Brad Mason, Chief Executive Officer, and Doug Rice, […]

ConforMIS Reports Fourth Quarter and the Year Ended 2016 Financial Results; Provides 2017 Financial Guidance
Financial

ConforMIS Reports Fourth Quarter and the Year Ended 2016 Financial Results; Provides 2017 Financial Guidance

BEDFORD, Mass., Feb. 15, 2017 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are customized to fit each patient’s unique anatomy, announced today financial results for the fourth quarter and the […]